Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic review. - Burman W; Luczynski P; Horsburgh CR; Phillips PPJ; Johnston J (The Lancet. Infectious diseases, 2025)